Acumen Pharmaceuticals, Inc. (ABOS)
Biological Products, (No Diagnostic Substances)
Latest Price
$2.15
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
1.38
P/B Ratio
1.55
Institutional Ownership
61.9% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 20.99M | $49.0M | 29.06% | +6.06M | 2026-03-31 |
| Sands Capital Alternatives, LLC | 3.72M | $8.0M | 5.15% | +303.0K | 2026-03-31 |
| Alyeska Investment Group, L.P. | 2.45M | $5.0M | 3.40% | +1.52M | 2026-03-31 |
| FRANKLIN RESOURCES INC | 2.31M | $5.0M | 3.19% | -- | 2026-03-31 |
| ADAR1 Capital Management, LLC | 2.16M | $5.0M | 2.99% | +1.27M | 2026-03-31 |
| Knollwood Investment Advisory, LLC | 1.63M | $3.0M | 2.25% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.51M | $3.0M | 2.09% | -- | 2026-03-31 |
| FMR LLC | 1.16M | $2.0M | 1.60% | -870.2K | 2026-03-31 |
| Ikarian Capital, LLC | 1.05M | $2.0M | 1.46% | +799.5K | 2026-03-31 |
| Hudson Bay Capital Management LP | 968.9K | $2.0M | 1.34% | +243.9K | 2026-03-31 |